BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9583676)

  • 1. The kinase activity of c-Abl but not v-Abl is potentiated by direct interaction with RFXI, a protein that binds the enhancers of several viruses and cell-cycle regulated genes.
    Agami R; Shaul Y
    Oncogene; 1998 Apr; 16(14):1779-88. PubMed ID: 9583676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p140/c-Abl that binds DNA is preferentially phosphorylated at tyrosine residues.
    Dikstein R; Agami R; Heffetz D; Shaul Y
    Proc Natl Acad Sci U S A; 1996 Mar; 93(6):2387-91. PubMed ID: 8637883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity.
    Wen ST; Van Etten RA
    Genes Dev; 1997 Oct; 11(19):2456-67. PubMed ID: 9334312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr.
    Ling X; Ma G; Sun T; Liu J; Arlinghaus RB
    Cancer Res; 2003 Jan; 63(2):298-303. PubMed ID: 12543778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro.
    Van Etten RA; Debnath J; Zhou H; Casasnovas JM
    Oncogene; 1995 May; 10(10):1977-88. PubMed ID: 7539119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drosophila abelson interacting protein (dAbi) is a positive regulator of abelson tyrosine kinase activity.
    Juang JL; Hoffmann FM
    Oncogene; 1999 Sep; 18(37):5138-47. PubMed ID: 10498863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines.
    Brasher BB; Van Etten RA
    J Biol Chem; 2000 Nov; 275(45):35631-7. PubMed ID: 10964922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dok-R binds c-Abl and regulates Abl kinase activity and mediates cytoskeletal reorganization.
    Master Z; Tran J; Bishnoi A; Chen SH; Ebos JM; Van Slyke P; Kerbel RS; Dumont DJ
    J Biol Chem; 2003 Aug; 278(32):30170-9. PubMed ID: 12777393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
    Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
    Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle.
    Welch PJ; Wang JY
    Cell; 1993 Nov; 75(4):779-90. PubMed ID: 8242749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling.
    Li S; Couvillon AD; Brasher BB; Van Etten RA
    EMBO J; 2001 Dec; 20(23):6793-804. PubMed ID: 11726515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage.
    Yuan ZM; Shioya H; Ishiko T; Sun X; Gu J; Huang YY; Lu H; Kharbanda S; Weichselbaum R; Kufe D
    Nature; 1999 Jun; 399(6738):814-7. PubMed ID: 10391251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DNA binding domain of the human c-Abl tyrosine kinase preferentially binds to DNA sequences containing an AAC motif and to distorted DNA structures.
    David-Cordonnier MH; Hamdane M; Bailly C; D'Halluin JC
    Biochemistry; 1998 Apr; 37(17):6065-76. PubMed ID: 9558345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity.
    Dai Z; Pendergast AM
    Genes Dev; 1995 Nov; 9(21):2569-82. PubMed ID: 7590236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of Bruton's tyrosine kinase by c-Abl.
    Bäckesjö CM; Vargas L; Superti-Furga G; Smith CI
    Biochem Biophys Res Commun; 2002 Dec; 299(3):510-5. PubMed ID: 12445832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of c-Abl by protein kinase Pak2 regulates differential binding of ABI2 and CRK.
    Jung JH; Pendergast AM; Zipfel PA; Traugh JA
    Biochemistry; 2008 Jan; 47(3):1094-104. PubMed ID: 18161990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An intramolecular SH3-domain interaction regulates c-Abl activity.
    Barilá D; Superti-Furga G
    Nat Genet; 1998 Mar; 18(3):280-2. PubMed ID: 9500553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SH2 domain of Abl kinases regulates kinase autophosphorylation by controlling activation loop accessibility.
    Lamontanara AJ; Georgeon S; Tria G; Svergun DI; Hantschel O
    Nat Commun; 2014 Nov; 5():5470. PubMed ID: 25399951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SH3 domain of Itk/Emt binds to proline-rich sequences in the cytoplasmic domain of the T cell costimulatory receptor CD28.
    Marengère LE; Okkenhaug K; Clavreul A; Couez D; Gibson S; Mills GB; Mak TW; Rottapel R
    J Immunol; 1997 Oct; 159(7):3220-9. PubMed ID: 9317120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.